Avantax Advisory Services, Inc. Pfizer Inc Transaction History

Avantax Advisory Services, Inc.

$13.8 Billion
Q2 2024

A detailed history of Avantax Advisory Services, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 308,754 shares of PFE stock, worth $9.19 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

308,754

Previous 292,081 5.71%

Holding current value

$9.19 Million

Previous $8.11 Million 6.58%

% of portfolio

0.06%

Previous 0.07%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $421,159 - $493,520	16,673 Added 5.71%	308,754 $8.64 Million
Q1 2024 May 08, 2024	SELL	$25.89 - $29.73 $645,515 - $741,258	-24,933 Reduced 7.86%	292,081 $8.11 Million
Q4 2023 Feb 07, 2024	BUY	$26.13 - $33.94 $493,857 - $641,466	18,900 Added 6.34%	317,014 $9.13 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $584,326 - $683,019	18,209 Added 6.51%	298,114 $9.89 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $108,468 - $125,495	3,003 Added 1.08%	279,905 $10.3 Million
Q1 2023 Apr 28, 2023	BUY	$39.39 - $51.28 $1.98 Million - $2.58 Million	50,267 Added 22.18%	276,902 $11.3 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $2.13 Million - $2.78 Million	-51,019 Reduced 18.38%	226,635 $11.6 Million
Q3 2022 Nov 01, 2022	BUY	$43.76 - $53.42 $703,179 - $858,405	16,069 Added 6.14%	277,654 $12.2 Million
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $741,315 - $878,968	15,932 Added 6.49%	261,585 $13.7 Million
Q1 2022 Apr 27, 2022	BUY	$45.75 - $56.69 $241,514 - $299,266	5,279 Added 2.2%	245,653 $12.7 Million
Q4 2021 Jan 24, 2022	BUY	$41.32 - $61.25 $354,690 - $525,770	8,584 Added 3.7%	240,374 $14.2 Million
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $249,904 - $321,024	6,367 Added 2.82%	231,790 $9.97 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $491,105 - $556,339	13,676 Added 6.46%	225,423 $8.83 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $40,522 - $45,701	1,210 Added 0.57%	211,747 $7.66 Million
Q4 2020 Jan 22, 2021	SELL	$33.47 - $42.56 $6.43 Million - $8.18 Million	-192,251 Reduced 47.73%	210,537 $7.75 Million
Q3 2020 Oct 14, 2020	BUY	$31.75 - $37.25 $8.23 Million - $9.65 Million	259,108 Added 180.34%	402,788 $14.8 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $31,686 - $38,440	1,052 Added 0.74%	143,680 $4.7 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $433,344 - $619,155	-16,032 Reduced 10.1%	142,628 $4.66 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $1.03 Million - $1.17 Million	31,217 Added 24.49%	158,660 $6.22 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $229,411 - $297,479	7,061 Added 5.87%	127,443 $4.58 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $494,311 - $554,997	13,367 Added 12.49%	120,382 $5.22 Million
Q1 2019 May 13, 2019	BUY	$37.5 - $41.2 $385,800 - $423,865	10,288 Added 10.64%	107,015 $4.55 Million
Q4 2018 Feb 13, 2019	BUY	$38.47 - $43.86 $3.72 Million - $4.24 Million	96,727 New	96,727 $4.22 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.

Account

Avantax Advisory Services, Inc. Pfizer Inc Transaction History